Defense‑tech startup Warhound announced a $200 million financing round on October 22, aimed at scaling its program to breed and clone high‑performance canines for the U.S. military, law‑enforcement agencies and first responders. Founded by Ben Lamm and Palmer Luckey, the company builds on its earlier work with dire‑wolf genetics, now turning to genetically engineered "warhounds" that combine superior stamina, obedience and sensory capabilities. The fresh capital, sourced from undisclosed investors, will fund advanced cloning facilities, field testing, and regulatory compliance efforts.
Industry analysts see Warhound’s model as a controversial but potentially transformative approach to battlefield support, promising faster deployment of trained dogs while reducing reliance on traditional breeding cycles. Critics warn about ethical concerns and the long‑term welfare of engineered animals, suggesting that public scrutiny and policy frameworks will shape the venture’s trajectory in the coming years.
This story was written by a language model from reporting by USA Today. Check the original before quoting it.